Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clinical Trial, Phase 1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT05602142
What this trial is testing

Study of [11C]CPPC as a Clinical PET Radioligand Biomarker of Microglial Activation in ALS

Who this might be right for
ALS
Johns Hopkins University 20
Early research (Phase 1)Study completedNCT00864942
What this trial is testing

Trial of Bendamustine, Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin's Lymphoma (NHL)

Who this might be right for
Chronic Lymphocytic LeukemiaNon-Hodgkin's Lymphoma
Georgetown University 28
Early research (Phase 1)Ended earlyNCT03739138
What this trial is testing

Intratumoral/Intralesional Administration of MK-4621/JetPEI™ With or Without Pembrolizumab in Participants With Advanced/Metastatic or Recurrent Solid Tumors (MK-4621-002)

Who this might be right for
Advanced Solid Tumors
Merck Sharp & Dohme LLC 30
Early research (Phase 1)Looking for participantsNCT06569758
What this trial is testing

GenSci098 in Subjects With Active Thyroid Eye Disease

Who this might be right for
SafetyTolerabilityGenSci098+1 more
Changchun GeneScience Pharmaceutical Co., Ltd. 76
Testing effectiveness (Phase 2)Study completedNCT02853344
What this trial is testing

Study of Pembrolizumab (MK-3475) Monotherapy in Locally Advanced/Metastatic Renal Cell Carcinoma (MK-3475-427/KEYNOTE-427)

Who this might be right for
Renal Cell Carcinoma
Merck Sharp & Dohme LLC 275
Early research (Phase 1)UnknownNCT05192512
What this trial is testing

Clinical Trial of the TQB2928 Injection in Patients With Advanced Cancers

Who this might be right for
Advanced Cancer
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. 180
Early research (Phase 1)Study completedNCT03602612
What this trial is testing

T Cells Expressing a Novel Fully-Human Anti-BCMA CAR for Treating Multiple Myeloma

Who this might be right for
Myeloma-MultipleMyeloma, Plasma-Cell
National Cancer Institute (NCI) 35
Early research (Phase 1)Looking for participantsNCT07030712
What this trial is testing

A Clinical Study of MK-8294 in Participants With Advanced Solid Tumors (MK-8294-001)

Who this might be right for
Metastatic Neoplasm
Merck Sharp & Dohme LLC 67
Early research (Phase 1)UnknownNCT05555212
What this trial is testing

To Evaluate the Efficacy of QLH11811 in Advanced NSCLC Patients With EGFR Mutation

Who this might be right for
Non-small Cell Lung Cancer
Qilu Pharmaceutical Co., Ltd. 72
Early research (Phase 1)Looking for participantsNCT05885412
What this trial is testing

A Phase 1, Dose Escalation Trial of RP-A601 in Subjects With PKP2 Variant-Mediated Arrhythmogenic Cardiomyopathy (PKP2-ACM)

Who this might be right for
PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM)
Rocket Pharmaceuticals Inc. 9
Testing effectiveness (Phase 2)Looking for participantsNCT06970119
What this trial is testing

A Multicenter, Open-label, Non-randomized Phase I/IIa Clinical Trial to Evaluate INR102 Injection in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Yunhe Pharmaceutical (Tianjin) Co., Ltd 55
Testing effectiveness (Phase 2)Study completedNCT04563377
What this trial is testing

Safety and Immunogenicity of Candidate HIV Vaccines Given Sequentially

Who this might be right for
Healthy
University of Oxford 10
Early research (Phase 1)Active Not RecruitingNCT05853367
What this trial is testing

Study of MK-0472 in Participants With Advanced/Metastatic Solid Tumors (MK-0472-001)

Who this might be right for
Metastatic Solid TumorsAdvanced Solid Tumors
Merck Sharp & Dohme LLC 95
Early research (Phase 1)Looking for participantsNCT07551167
What this trial is testing

A Clinical Study of HRS-5765 in Healthy Participants

Who this might be right for
Heart Failure
Chengdu Suncadia Medicine Co., Ltd. 74
Early research (Phase 1)Study completedNCT03330899
What this trial is testing

Safety and Immunogencity of H7N9 Influenza Antigen With 2 Adjuvant Formulations in Healthy Adults in Brazil

Who this might be right for
InfluenzaH7N9 Influenza
Butantan Institute 432
Early research (Phase 1)Study completedNCT01743222
What this trial is testing

Intralymphatic eASC Administration in Healthy Volunteers

Who this might be right for
Localized Adverse Reaction to Administration of Drug
Tigenix S.A.U. 10
Early research (Phase 1)Study completedNCT00980239
What this trial is testing

HAI Irinotecan + IV Bevacizumab, Bevacizumab & Oxaliplatin or Bevacizumab & Cetuximab in Advanced Cancers Metastatic to Liver

Who this might be right for
Liver CancerAdvanced Cancer
M.D. Anderson Cancer Center 115
Large-scale testing (Phase 3)Study completedNCT05492409
What this trial is testing

Study of the Safety and Immunogenicity of Long-term GNR-069 Therapy in ITP Patients

Who this might be right for
Idiopathic Thrombocytopenic Purpura
AO GENERIUM 160
Testing effectiveness (Phase 2)Looking for participantsNCT06709495
What this trial is testing

Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas

Who this might be right for
SarcomaSarcoma, EwingDesmoplastic Small Round Cell Tumor+3 more
David S Shulman, MD 63
Early research (Phase 1)Study completedNCT01206465
What this trial is testing

Pralatrexate and Fluorouracil in Treating Patients With Recurrent Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
University of Nebraska 29
Next Page